Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

NCT07145255 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer Castration-resistant Prostate Cancer
Breast Cancer
Colo-rectal Cancer
Lung Cancer (Non-Small Cell)
Pancreas Cancer, Duct Cell Adenocarcinoma

Interventions

DRUG: ADC

Sponsor

MBrace Therapeutics